The identification of new oncology biomarkers and the availability of sequencing data from patients is changing the way physicians manage the care of cancer patients. IntegraGen is at the forefront of discovering biomarkers and the development of clinical tools which will help to personalize care and improve outcomes for individuals with cancer.